Predictors of treatment acceptance and completion in anorexia nervosa: Implications for future study designs

Archives of General Psychiatry

Volumn 62, Issue 7, 2005, Pages 776-781

  Halmi, Katherine A ^a   Agras, W Stewart ^b   Crow, Scott ^c   Mitchell, James ^d   Wilson, G Terence ^e   Bryson, Susan W ^b   Kraemer, Helena C ^b  

^a WEILL CORNELL MEDICAL COLLEGE   (United States)

^b STANFORD UNIVERSITY SCHOOL OF MEDICINE   (United States)

^c UNIVERSITY OF MINNESOTA MEDICAL SCHOOL   (United States)

^d UND School of Medicine & Health Sciences Southeast Campus   (United States)

^e RUTGERS UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

FLUOXETINE; SEROTONIN UPTAKE INHIBITOR;

ADULT; ANOREXIA NERVOSA; ARTICLE; BEHAVIOR THERAPY; CLINICAL TRIAL; COGNITIVE THERAPY; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DIAGNOSTIC AND STATISTICAL MANUAL OF MENTAL DISORDERS; HUMAN; MAJOR CLINICAL STUDY; OBSESSION; PATIENT COMPLIANCE; PREDICTION; PSYCHIATRIC TREATMENT; PSYCHOPHARMACOTHERAPY; RANDOMIZATION; RANDOMIZED CONTROLLED TRIAL; SELF ESTEEM; TREATMENT OUTCOME; UNITED STATES; ADOLESCENT; COMPARATIVE STUDY; FEMALE; MIDDLE AGED; MULTICENTER STUDY; MULTIMODALITY CANCER THERAPY; PATIENT; PATIENT ATTITUDE; PROBABILITY; PROSPECTIVE STUDY; PSYCHOLOGICAL ASPECT; PSYCHOLOGICAL RATING SCALE; SELF CONCEPT; STATISTICS;

ADOLESCENT; ADULT; ANOREXIA NERVOSA; COGNITIVE THERAPY; COMBINED MODALITY THERAPY; FEMALE; FLUOXETINE; HUMANS; MIDDLE AGED; PATIENT ACCEPTANCE OF HEALTH CARE; PATIENT DROPOUTS; PROBABILITY; PROSPECTIVE STUDIES; PSYCHIATRIC STATUS RATING SCALES; SELF CONCEPT; SEROTONIN UPTAKE INHIBITORS; TREATMENT OUTCOME;

EID: 21744444467     PISSN: 0003990X     EISSN: 15383636     Source Type: Journal    
DOI: 10.1001/archpsyc.62.7.776     Document Type: Article

References (22)

1. Crow SJ, Peterson CB. The economic and social burden of eating disorders: a review. In: Maj M, Halmi K, Lopez-Ibor J, Sartorius N, eds. Eating Disorders. Chichester, England: John Wiley & Sons Ltd; 2003:383-397.
2. Kleifield EI, Wagner S, Halmi KA. Cognitive-behavioral treatment of anorexia nervosa: eating disorders. Psychiatr Clin North Am. 1996;19:715-734.
3. Zwann M, Roerig J. Pharmacological treatment of eating disorders: a review. In: Maj M, Halmi K, Lopez-Ibor J, Sartorius N, eds. Eating Disorders. Chichester, England: John Wiley & Sons Ltd; 2003:223-286.
4. Kaye WH, Nagata T, Weltzin T, Hsu G, Sokol M, McConaha C, Plotnicov KH, Weise J, Deep D. Double-blind placebo-controlled administration of fluoxetine in restricting-and restricting-purging-type anorexia nervosa. Biol Psychiatry. 2001; 49:644-652.
5. Garner DM, Vitousek KM, Pike KM. Cognitive-behavioral therapy for anorexia nervosa. In: Garner PE, Garfinkel P, eds. Handbook of Treatment for Eating Disorders. New York, NY: Guilford Press; 1997:94-144.
6. Serfaty MA, Turkington D, Heap M, Ledsham L, Jolley E. Cognitive therapy versus dietary counseling in the outpatient treatment of anorexia nervosa: effects of the treatment phase. Eur Eat Disord Rev. 1999;7:334-350.
7. Pike KM, Walsh BT, Vitousek K, Wilson GT, Bauer J. Cognitive behavioral therapy in the relapse prevention of anorexia nervosa. Paper presented at: Eating Disorder Research Society Meeting; November 10, 2000; Munich, Germany.
8. Keel PK, Dorer D-J, Eddy KT, Delinsky SS, Franko DL, Blais MA, Keller MB, Herzog D. Predictors of treatment utilization among women with anorexia and bulimia nervosa. Am J Psychiatry. 2002;159:140-142.
9. Spitzer RL, Williams JBW, Gibbon M. Structured Clinical Interview for DSMIII-R (SCID). New York: Biometrics Research, New York State Psychiatric Institute; 1987.
10. Smith DW. Measurements, methods and standards. In: Smith DW, ed. Growth and Its Disorders. Philadelphia, Pa: WB Saunders Co; 1997:18-20.
11. Frisch RE. The right weight: body fat, menarche and ovulation. Baillieres Clin Obstet Gynaecol. 1990;4:419-425.
12. Kraemer HC. Evaluating Medical Tests: Objective and Quantitative Guidelines. Newbury Park, Calif: Sage Publications; 1992.
13. Goodman WK, Price LH, Rasmussen SA, Mazure C, Fleishman RL, Hill CL, Heninger GR, Charney DS. The Yale-Brown Obsessive-Compulsive Scale: development, use and reliability. Arch Gen Psychiatry. 1989;46:1012-1016.
14. Weissman MM, Bothwell S. Assessment of social adjustment by patient self-report. Arch Gen Psychiatry. 1976;33:1111-1115.
15. Tellegen A, Waller N. Exploring personality through test construction: development of the Multidimensional Personality Questionnaire. In: Briggs SR, Cheek JM, eds. Personality Measures: Development and Evaluation. Vol 1. Greenwich, Conn: JAI Press; 1994:172-208.
16. Beck AT, Ward CH, Mendelson M, Mock J, Erbaugh J. An inventory for measuring depression. Arch Gen Psychiatry. 1961;4:561-571.
17. Cooper Z, Fairburn CG. The Eating Disorder Examination: a semi-structured interview for the assessment of the specific psychopathology of eating disorders. Int J Eat Disord. 1987;6:1-8.
18. Stunkard AJ, Messick S. The Three-Factor Eating Questionnaire to measure dietary restraint, disinhibition, and hunger. J Psychosom Res. 1985;29:71-83.
19. Levine J, Schooler N. Systematic Assessment for Emergent Event (SAFTEE) Symptoms. Rockville, Md: Pharmacologic and Somatic Treatment Branch, National Institute of Mental Health; 1983.
20. Mazure CM, Halmi KA, Sunday SR, Romano SJ, Einhorn AM. The Yale-Brown-Cornell Eating Disorder Scale: development, use, reliability and validity. J Psychiatr Res. 1994;28:425-445.
21. Rosenberg M. Conceiving the Self. New York, NY: Basic Books; 1979.
22. Braun DL, Sunday SR, Halmi KA. Psychiatric comorbidity in patients with eating disorders. Psychol Med. 1994;24:859-867.